case_images: PMC10124569_01
case_images: Slit lamp examination at initial presentation revealed (A) a localized hyperemia and (B) redundant folds (pointed with black arrows) of the superior bulbar conjunctiva.
case_images: OPTO-15-75-g0001.jpg
case_images: PMC10124569_01_OPTO-15-75-g0001.jpg
case_images: f0001
case_images: At slit lamp examination, the LE showed significant conjunctival hyperemia and redundancy in the superior bulbar area (Figure 1).
case_images: Meibography examination revealed grade 1 meibomian gland loss on superior eyelid of (A) right eye and (B) left eye.
case_images: OPTO-15-75-g0002.jpg
case_images: PMC10124569_01_OPTO-15-75-g0002.jpg
case_images: f0002
case_images: Meibography (Oculus Keratograph 5M, Oculus, Wetzlar, Germany) was performed to evaluate the degree and severity of MGD in both eyes (Figure 2) which revealed grade 1 meibomian gland loss.
case_images: Slit lamp examination at (A) three months and (B) two years after treatment commencement showed significant reduction of the inflammation over the superior bulbar conjunctiva.
case_images: OPTO-15-75-g0003.jpg
case_images: PMC10124569_01_OPTO-15-75-g0003.jpg
case_images: f0003
case_images: Slit lamp examination revealed significant reduction of inflammation on the superior bulbar conjunctiva of the LE (Figure 3A), and no fluorescein staining was visible. Mild superior conjunctival hyperemia without fluorescein staining was found on examination of the LE (Figure 3B).